| Recruiting | Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Meta Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced or Metastatic Breast Cancer, BRCA1 Mutation | Phase 2 | 2024-12-13 |
| Recruiting | Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer CCCA Assessed by Ki67 Drop Below <2.7% From Baseline | Phase 2 | 2024-12-04 |
| Recruiting | Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Canc HER2-positive Breast Cancer | Phase 2 | 2023-01-02 |
| Recruiting | Long-term Safety and Efficacy of GBG Study Participants Breast Cancer | — | 2022-10-12 |
| Active Not Recruiting | Sacituzumab Govitecan in Primary HER2-negative Breast Cancer HER2-negative Breast Cancer, Triple Negative Breast Cancer | Phase 3 | 2020-10-28 |
| Completed | Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer Breast Cancer Metastatic | Phase 2 | 2018-03-15 |
| Completed | A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Metastatic Breast Cancer | Phase 4 | 2018-03-01 |
| Completed | Denosumab as an add-on Neoadjuvant Treatment (GeparX) Breast Cancer Female NOS, Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II | Phase 2 | 2017-02-13 |
| Completed | Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirub Breast Cancer, Triple Negative Breast Neoplasms, HRpos Breast Neoplasms | Phase 2 | 2016-09-01 |
| Completed | Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer Breast Cancer | Phase 2 | 2016-06-01 |
| Completed | Dose EScalation Induction of EvERolimus Breast Cancer, Hormone Receptor Positive Tumor | Phase 2 | 2015-05-01 |
| Completed | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treat Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III, Mucinous Breast Cancer Stage II | Phase 3 | 2014-12-01 |
| Completed | A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Pa Breast Cancer, Hormonreceptor Positive, Her2-normal | Phase 3 | 2013-10-30 |
| Terminated | Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane Metastatic Breast Cancer | Phase 3 | 2013-07-01 |
| Completed | Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Primary Breast Cancer | Phase 2 | 2013-02-01 |
| Completed | Study of Nab-Paclitaxel in High Risk Early Breast Cancer Breast Cancer | Phase 3 | 2012-09-01 |
| Completed | Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients Male Breast Cancer | Phase 3 | 2012-08-01 |
| Completed | Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II, Breast Cancer Female NOS | Phase 3 | 2012-07-01 |
| Completed | Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Ope Unilateral HER2 Positive Breast Cancer | Phase 2 | 2012-05-01 |
| Terminated | Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA) Metastatic Breast Cancer | Phase 2 | 2012-02-01 |
| Completed | Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II, Breast Cancer Female NOS | Phase 2 / Phase 3 | 2011-08-01 |
| Terminated | Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany) Metastatic Breast Cancer | Phase 2 | 2011-07-01 |
| Completed | Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 1 | 2010-10-01 |
| Terminated | A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Breast Cancer | Phase 3 | 2009-07-01 |
| Completed | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma Breast Cancer | Phase 2 / Phase 3 | 2009-03-01 |
| Completed | Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer Breast Cancer | Phase 2 | 2007-11-01 |
| Completed | Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer Breast Cancer | Phase 3 | 2007-10-01 |
| Unknown | Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases Breast Cancer | Phase 2 | 2006-12-01 |
| Completed | Mono Efficacy of Capecitabine (MoniCa) Breast Cancer | Phase 2 | 2005-07-01 |
| Completed | A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First Metastatic Breast Cancer | Phase 1 | 2005-07-01 |
| Completed | Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) Breast Cancer | Phase 2 | 2005-03-01 |
| Completed | Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Breast Cancer | Phase 3 | 2005-01-01 |
| Completed | Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy Breast Cancer | Phase 3 | 2004-12-01 |
| Completed | A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Breast Cancer | Phase 3 | 2004-07-01 |
| Completed | Study in Elderly Patients With Early Breast Cancer (ICE) Breast Cancer | Phase 3 | 2004-06-01 |
| Completed | TBP Study With Capecitabine Plus Minus Trastuzumab Breast Cancer | Phase 3 | 2003-09-01 |
| Recruiting | Breast Cancer in Pregnancy Register Study Breast Cancer | — | 2003-04-01 |
| Completed | Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Breast Cancer | Phase 3 | 2002-09-01 |
| Completed | Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) Breast Cancer | Phase 3 | 2002-08-01 |
| Completed | Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) Breast Cancer | Phase 2 | 2002-01-01 |
| Completed | German Preoperative Adriamycin Docetaxel Study Breast Neoplasms | Phase 2 | 1998-04-01 |
| Completed | Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Doce Primary Breast Cancer | Phase 3 | — |